Download PDF
1 / Pages

Other users also viewed these articles

Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP) Laura Francisco; Marta Cruz-Cañete; Carlos Pérez; José Antonio Couceiro; Enrique Otheo; Cristian Launes; Carlos Rodrigo; Ana Belén Jiménez; Marta Llorente; Abián Montesdeoca; José Rumbao; Cristina Calvo; Susana Frago; Alfredo Tagarro;
An Pediatr (Barc). 2023;99:257-63
Respiratory syncytial virus infections requiring hospitalization in patients with primary immunodeficiency Luis Ignacio González-Granado; Andrea Martín-Nalda; Laia Alsina; Olaf Neth; Manuel Santamaría; Pere Soler-Palacín;
An Pediatr (Barc). 2022;96:492-500
Update of the Spanish clinical practice guideline for urinary tract infection in infants and children. Summary of recommendations for diagnosis, treatment and follow-up Juan David González Rodríguez; Gloria María Fraga Rodríguez; César Joaquín García Vera; Andrés Gómez Fraile; Juan Ignacio Martín Sánchez; José María Mengual Gil; Carlos Ochoa Sangrador; Blanca Valenciano Fuentes; Joaquín Escribano Subías;
An Pediatr (Barc). 2024;101:132-44